Tianci International, Inc. - Form 8-K Summary
Business Context and Reporting Period
Tianci International, Inc. (Nasdaq: CIIT), a Nevada corporation, filed this Current Report on October 29, 2025. The company is headquartered in Hong Kong and its common stock trades on the Nasdaq Capital Market.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes
The company received a deficiency letter from Nasdaq notifying it that the closing bid price of its Common Stock was below the minimum $1.00 per share requirement for 30 consecutive business days. This constitutes a failure to satisfy Nasdaq Listing Rule 5550(a)(2).
Outlook, Risks, and Management Commentary
- Compliance Period: Tianci has been granted 180 calendar days, until April 27, 2026, to regain compliance.
- Compliance Criteria: To regain compliance, the closing bid price must be at least $1.00 for a minimum of 10 consecutive business days before the Compliance Date.
- Delisting Risk: If compliance is not achieved by April 27, 2026, and the company is not eligible for an additional grace period (based on market value of publicly held shares and other initial listing standards), the stock will be subject to delisting.
- Appeal Rights: In the event of a delisting determination, the company may appeal to a Nasdaq Hearings Panel.
- Management Action: Management intends to monitor the stock price and consider available options to regain compliance.
Investor Verification Checklist
- Verify the current closing bid price of CIIT to assess proximity to the $1.00 threshold.
- Monitor the stock price for 10 consecutive business days to determine if the company can secure early compliance confirmation.
- Review the company's market value of publicly held shares to determine eligibility for an additional grace period if the April 27, 2026 deadline is missed.
- Check for any subsequent filings regarding stock splits or other corporate actions intended to address the bid price deficiency.